Monthly Vistors
May 2022
May 2022
HF Stage A
40
40
HF Stage B
90
90
HF Stage C
70
70
HF Stage D
25
25
Monthly Vistors
March 2022
March 2022
HF Stage A
32
32
HF Stage B
30
30
HF Stage C
50
50
HF Stage D
343
343
Monthly Vistors
January 2022
January 2022
HF Stage A
50
50
HF Stage B
30
30
HF Stage C
40
40
HF Stage D
60
60
Monthly Vistors
December 2021
December 2021
HF Stage A
50
50
HF Stage B
30
30
HF Stage C
10
10
HF Stage D
15
15
Monthly Vistors
November 2021
November 2021
HF Stage A
323
323
HF Stage B
111
111
HF Stage C
213
213
HF Stage D
123
123
Monthly Vistors
October 2021
October 2021
HF Stage A
200
200
HF Stage B
132
132
HF Stage C
23
23
HF Stage D
343
343
Monthly Vistors
September 2021
September 2021
HF Stage A
250
250
HF Stage B
120
120
HF Stage C
122
122
HF Stage D
50
50
HF Stage A Patients at high risk for developing HF in the future but no functional or structural heart disorder
HF Stage B A structural heart disorder but no symptoms at this stage
HF Stage C Previous or current symptoms of heart failure in the context of an underly ing structural heart problem, but managed with medical treatment
HF Stage D Advanced disease requiring hospital-based support, a heart transplant or palliative care
HF Stage B A structural heart disorder but no symptoms at this stage
HF Stage C Previous or current symptoms of heart failure in the context of an underly ing structural heart problem, but managed with medical treatment
HF Stage D Advanced disease requiring hospital-based support, a heart transplant or palliative care